All these studies support both the therapeutic and prognostic potential of hCLCA1 in rectal cancers, although the mechanisms by which hCLCA1 suppresses tumor growth may beyond inhibiting the Wnt/β-catenin signaling network and EMT process. This evidence concerns the gene CLCA1 and rectal cancer.